Please try another search
For the three months ended 31 March 2012, Psycheceutical Bioscience Inc revenues increased 79% to $319K. Net income totaled $116K vs. loss of $56K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Other income increase from $4K to $59K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.04 to $0.09.
Period Ending: | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 |
---|---|---|---|---|
Total Revenue | 0.32 | 0.36 | 0.24 | 0.24 |
Gross Profit | 0.27 | 0.26 | 0.06 | 0.11 |
Operating Income | 0.1 | -0 | -0.14 | -0.13 |
Net Income | 0.12 | 0.02 | -0.16 | -0.12 |
Period Ending: | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 |
---|---|---|---|---|
Total Assets | 1.96 | 1.8 | 1.7 | 1.77 |
Total Liabilities | 1.52 | 1.48 | 1.39 | 1.31 |
Total Equity | 0.44 | 0.32 | 0.31 | 0.46 |
Period Ending: | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | 0.17 | 0.01 | -0.15 | -0.09 |
Cash From Investing Activities | 0 | 0 | 0 | |
Cash From Financing Activities | -0.05 | 0.66 | 0.56 | 0.14 |
Net Change in Cash | 0.12 | 0.66 | 0.42 | 0.05 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review